Molecular Therapies
Schneider H, Schneider P (2025)
Publication Type: Book chapter / Article in edited volumes
Publication year: 2025
Publisher: Springer Nature
Edited Volumes: Multidisciplinary Approach to Ectodermal Dysplasia
City/Town: Cham
Pages Range: 189–196
ISBN: 9783031757907
DOI: 10.1007/978-3-031-75790-7_16
Abstract
This chapter describes the development of molecular therapies for X-linked hypohidrotic ectodermal dysplasia (XLHED), the most common ectodermal dysplasia syndrome, and for the cutaneous and ocular manifestations of p63-associated syndromes. Large parts of the text are based on the following previously published journal article by Holm Schneider: “Ectodermal dysplasias: New perspectives on the treatment of so far immedicable genetic disorders”, Front Genet. 13:1000744, doi: 10.3389/fgene.2022.1000744; available under the terms of the Creative Commons Attribution License (CC BY).
Authors with CRIS profile
Involved external institutions
Switzerland (CH)How to cite
APA:
Schneider, H., & Schneider, P. (2025). Molecular Therapies. In Gianluca Tadini, John Timothy Wright, Smaïl Hadj-Rabia, Holm Schneider (Eds.), Multidisciplinary Approach to Ectodermal Dysplasia. (pp. 189–196). Cham: Springer Nature.
MLA:
Schneider, Holm, and Pascal Schneider. "Molecular Therapies." Multidisciplinary Approach to Ectodermal Dysplasia. Ed. Gianluca Tadini, John Timothy Wright, Smaïl Hadj-Rabia, Holm Schneider, Cham: Springer Nature, 2025. 189–196.
BibTeX: Download